Sugarmate, Mac Glance Application

FDA UDI

Class I (US FDA UDI)

by Sugarmate, LLC

Identity

Trade Name: Sugarmate, Mac Glance Application FDA UDI
Generic Name: Self-care monitoring/reporting software FDA UDI
Model / Reference: 1008180 FDA UDI

Identifiers

Primary DI / UDI-DI: 00850018992602 FDA UDI
FDA Product Code: PHV FDA UDI
GMDN Term: Self-care monitoring/reporting software FDA UDI

Classification

Device Class: Class I FDA UDI
Regulation Number: 862.2120 FDA UDI
Commercial Distribution: In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

FDA UDI

Single Use

FDA UDI

Implantable

FDA UDI

Contains Latex

FDA UDI

Prescription Use

FDA UDI

Over-the-Counter

FDA UDI

Convenience Kit

FDA UDI

Combination Product

FDA UDI

HCT/P

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

FDA UDI

Serial Number

FDA UDI

Expiration Date

FDA UDI

Manufacturing Date

FDA UDI

Category: Self-care monitoring/reporting software

Sugarmate, Mac Glance Application by Sugarmate, LLC — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Self-care monitoring/reporting software.

MiniMed™ Mobile — MEDTRONIC MINIMED, INC. · Class II
Floodlight MS Draw Shape Test — Roche Molecular Systems, Inc. · Class I
DreamMapper iOS China Instance v 2.11 — Respironics, Inc. · Class II
Floodlight MS Cognitive Test — Roche Molecular Systems, Inc. · Class II
DreamMapper — Respironics, Inc. · Class II
Irregular Rhythm Notifications — APPLE INC. · Class II
DreamMapper App iOS — Respironics, Inc. · Class II
DreamMapper — Respironics, Inc. · Class II

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Source	Region	Type	Cert / Approval No.	Class	Status
FDA UDI	United States	FDA UDI	Registered in GUDID	Class I	Pending data

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer: Sugarmate, LLC

Sources (1)

FDA UDI 1af4779a-d84f-40cf-bcc8-ae09a012a9b1 32 fields · synced May 31, 2026